Feature | November 09, 2006 | Cristen C. Bolan

RSNA 2006 Stages the Changing Role of Radiology

As if RSNA wasn’t big enough, expect it to be even bigger this year. As the scope of radiology widens, so does the category of radiology subspecialties. RSNA 2006 has designed its program to reflect this change, adding to its curriculum important research across multiple radiology subspecialties – cardiac radiology, emergency radiology, neuroradiology, vascular and interventional radiology, breast/mammography, gastrointestinal radiology and genitourinary radiology, to name just a few. In light of molecular imaging’s tremendous potential for eradicating diseases — by revealing the early presence or likelihood of disease — molecular imaging will make its debut as a subspecialty area at this year’s RSNA.
Take note that the growing number of subspecialties is the precursor to the convergence of certain medical disciplines – principally radiology, pathology and cardiology – and manufacturers are poised to deliver new solutions for these anticipated developments.
Vendor participants at RSNA are also eager to show off their new product releases, many of which are inspired by growth areas in radiology, such as PET/CT and SPECT/CT hybrids, multislice CT, high channel MR, cardiac CT and MR, artificial intelligence and EMR/PACS solutions. Get a sneak peak at these in our extensive RSNA Preview in this issue.
The RSNA Scientific Program Committee is enthusiastic about this year’s presentations, which will introduce new approaches to fusion, perfusion/diffusion, multiplanar and dual energy imaging techniques, advancements in multislice CT, the explosion of cardiac CT, as well as novel CAD applications.
Imaging Technology News is looking forward to hitting the RSNA floor and seeing new technology in action. But we are especially interested in meeting our readers in person. So please stop by to see us at Booth #3915, or e-mail me to arrange a meeting in advance, [email protected].
See you at the show!

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init